CT News and Research

RSS

EMA CHMP recommends approval of linagliptin for type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.

24 Jun 2011

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has received an opinion on its Marketing Authorisation Application (MAA) for Glybera as a potential therapy for Lipoprotein Lipase Deficiency.

24 Jun 2011

Nontoxic gold nanoparticles could detect growth of early tumors in liver

Hepatocellular carcinoma is the most common cancer to strike the liver. More than 500,000 people worldwide, concentrated in sub-Saharan Africa and Southeast Asia, are diagnosed with it yearly. Most of those afflicted die within six months.

23 Jun 2011

Baptist Health System to open four new emergency hospitals in Alamo City

Baptist Health System, San Antonio's healthcare leader for more than a century, plans to open four new emergency hospitals in the Alamo City, bringing emergency medical care closer to home for many residents. The hospital system is partnering with emergency medicine pioneer Emerus to manage the facilities based on the company's successful model in other cities throughout Texas.

20 Jun 2011

Premier healthcare honors Toshiba with Supplier Performance Award

Toshiba America Medical Systems, Inc. today announced that it is a winner of the sixth annual Performance Award, presented by the Premier healthcare alliance.

20 Jun 2011

Children with head trauma after normal CT scans do not require neurosurgical intervention

A large, national multi-center study of thousands of children taken to emergency departments with minor blunt head trauma has found that most of those with normal computed tomography (CT) scans do not require hospitalization for further observation.

17 Jun 2011

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.

17 Jun 2011

Adaptimmune melanoma trial opening

Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.

16 Jun 2011

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

A new study from Rhode Island Hospital has found that MR enterography (MRE) without the use of an anti-peristaltic agent were as reliable as CT enterography (CTE) in determining the presence of Crohn's disease.

16 Jun 2011

ISCO discovers novel technology to produce pure hepatocyte population

International Stem Cell Corporation announces the discovery of a novel, patent-pending technology to produce unlimited numbers of liver cells (hepatocytes) that are free of contamination with potentially dangerous undifferentiated cells.

16 Jun 2011

Galectin strengthens cancer drug patent portfolio in Europe

Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".

15 Jun 2011

Dual Body scan machine gets FDA nod

According to the U.S. Food and Drug Administration last Friday, Siemens AG's device that simultaneously performs two common diagnostic tests received clearance from them. The German engineering company's U.S.-based Siemens Medical Solutions, which is based in Pennsylvania, manufactures the device.

From Siemens Healthineers 13 Jun 2011

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American Society of Echocardiography (ASE) annual meeting in Montreal, June 11-14, 2011, Toshiba America Medical Systems, Inc., will highlight cardiac and shared service ultrasound applications designed to improve cardiac ultrasound imaging.

13 Jun 2011

Bariatric surgery not linked with decreased risk of death among older obese patients

The use of bariatric surgery among older, severely obese patients was not associated with a decreased risk of death, according to a study in the June 15 issue of JAMA. This study is being released early online to coincide with its presentation at the AcademyHealth Annual Research Meeting.

13 Jun 2011

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Incyte Corporation announced today additional symptom improvement and quality of life (QoL) results from COMFORT-I, a randomized, double-blinded, placebo-controlled Phase III trial of Incyte's JAK1 and JAK2 inhibitor, ruxolitinib, in patients with myelofibrosis (MF).

13 Jun 2011

Siemens receives FDA clearance for Biograph mMR system to perform simultaneous PET/MRI scan

The U.S. Food and Drug Administration today cleared the Siemens Biograph mMR system, the first device to simultaneously perform a positron emission tomography scan, commonly known as PET scan, and a magnetic resonance imaging (MRI) scan.

From Siemens Healthineers 13 Jun 2011

U-M International Center for Automotive Medicine announces new collaborative research

The University of Michigan International Center for Automotive medicine this week marked the beginning of new capabilities and new collaborative research combining trauma medicine, state-of-the-art computer analysis and automotive engineering.

10 Jun 2011

Medical management preferred over surgery for pediatric orbital cellulitis

Researchers from Hasbro Children's Hospital in Providence, R.I., report that medical management may be preferred over surgery for children with orbital cellulitis, an acute infection of the tissues surrounding the eye. They have determined the criteria for surgical intervention should be dependent upon the size of a subperiosteal abscess (SPA).

9 Jun 2011

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

ZIOPHARM Oncology, Inc. announced today that Douglas J. Schwartzentruber, MD, FACS, of the Indiana University Health Goshen Center for Cancer Care, presented initial positive clinical results from the first-ever treatment demonstrating control over transgene encoding of a therapeutic anticancer protein in humans using a small molecule activator ligand.

7 Jun 2011

Ridaforolimus Phase III SUCCEED clinical trial on metastatic sarcoma meets primary endpoint

Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc.,, today announced the presentation of detailed results from the Phase III SUCCEED clinical trial. SUCCEED evaluated oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.

7 Jun 2011

CT News and Research

EMA CHMP recommends approval of linagliptin for type 2 diabetes

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

Nontoxic gold nanoparticles could detect growth of early tumors in liver

Baptist Health System to open four new emergency hospitals in Alamo City

Premier healthcare honors Toshiba with Supplier Performance Award

Children with head trauma after normal CT scans do not require neurosurgical intervention

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Adaptimmune melanoma trial opening

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

ISCO discovers novel technology to produce pure hepatocyte population

Galectin strengthens cancer drug patent portfolio in Europe

Dual Body scan machine gets FDA nod

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Bariatric surgery not linked with decreased risk of death among older obese patients

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Siemens receives FDA clearance for Biograph mMR system to perform simultaneous PET/MRI scan

U-M International Center for Automotive Medicine announces new collaborative research

Medical management preferred over surgery for pediatric orbital cellulitis

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

Ridaforolimus Phase III SUCCEED clinical trial on metastatic sarcoma meets primary endpoint

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News